Citation Impact

Citing Papers

Radical Cystectomy in the Treatment of Invasive Bladder Cancer: Long-Term Results in 1,054 Patients
2001 Standout
Cancer Biomarkers Defined by Autoantibody Signatures to Aberrant O-Glycopeptide Epitopes
2010
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
2016 Standout
Pediatric Percutaneous Nephrolithotomy: Assessing Impact of Technical Innovations on Safety and Efficacy
1999
Tuberous sclerosis complex
2000 Standout
Antifibrinolytic Additives to Fibrin Glue for Laparoscopic Wound Closure in Urinary Tract
1999
Systematic review and economic modelling of effectiveness and cost utility of surgical treatments for men with benign prostatic enlargement
2008
Guidelines on Urolithiasis<footref rid="foot01"><sup>1</sup></footref>
2001 Standout
TP53 Mutations in Human Cancers: Origins, Consequences, and Clinical Use
2009 Standout
Clinical utility of telomerase in cancer
2002
Endoscopy vs. Extracorporeal Shockwave Lithotripsy in the Treatment of Distal Ureteral Stones: Ten Years' Experience
1999
Increased expression of anterior gradient-2 is significantly associated with poor survival of prostate cancer patients
2007
Immortalized and tumorigenic adult human prostatic epithelial cell lines: Characteristics and applications part I. Cell markers and immortalized nontumorigenic cell lines
1996
Clusterin (SGP-2) transient overexpression decreases proliferation rate of SV40-immortalized human prostate epithelial cells by slowing down cell cycle progression
2002
Human prostate cancer risk factors
2004
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 Standout
Telomerase and tumorigenesis
2003
Epidemiology of Prostate Cancer
2019 Standout
Stimuli-responsive nanocarriers for drug delivery
2013 Standout
Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer
2003 Standout
Serum anti-p53 autoantibodies from patients with idiopathic pulmonary fibrosis associated with lung cancer
2000
High activity of mitochondrial glycerophosphate dehydrogenase and glycerophosphate-dependent ROS production in prostate cancer cell lines
2005
Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth
1997 Standout
Quality control in transurethral resection of bladder tumours
2008
Neuroendocrine differentiation in human prostate tissue: is it detectable and treatable?
2003
Structural Aspects of the p53 Protein in Relation to Gene Evolution: A Second Look
1996
Prediction of Survival in Stage I Lung Carcinoma Patients by Telomerase Function Evaluation
2002
Clusterin Is a Secreted Marker for a Hypoxia-Inducible Factor-Independent Function of the von Hippel-Lindau Tumor Suppressor Protein
2006 StandoutNobel
Bacterial biofilm formation on urologic devices and heparin coating as preventive strategy
2004
Fibroblast growth factor signalling: from development to cancer
2010 Standout
p21 in cancer: intricate networks and multiple activities
2009 Standout
Measuring the multifaceted roles of mucin-domain glycoproteins in cancer
2022 StandoutNobel
Delivery of siRNA mediated by histidine-containing reducible polycations
2008
Clinical use of tumor markers in oncology
1991
Antioxidant therapy for treatment of inflammatory bowel disease: Does it work?
2015 Standout
Pulmonary Lymphangioleiomyomatosis: A Study of 69 Patients
1999
The chemopreventive action of catechins in the TRAMP mouse model of prostate carcinogenesis is accompanied by clusterin over-expression
2004
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
2016 Standout
Further clinical experience with the ileal W‐neobladder and a serous‐lined extramural tunnel for orthotopic substitution
1995
Multifactorial analysis of p53 alteration in human cancer: A review
1994
A systematic review of humoral immune responses against tumor antigens
2009
Nerve‐sparing robot‐assisted radical cystoprostatectomy and urinary diversion
2003 Standout
The Emerging Hallmarks of Cancer Metabolism
2016 Standout
p53 and Human Cancer: The First Ten Thousand Mutations
1999
EAU Guidelines on the Treatment and Follow-up of Non-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction
2013 Standout
Prostate Cancer
2003 StandoutNobel
Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy
2009 Standout
Paradoxical roles of the immune system during cancer development
2006 Standout
The ‘wildtype’ conformation of p53: epitope mapping using hybrid proteins
2001 StandoutNobel
A simplified immunoprecipitation method for quantitatively measuring antibody responses in clinical sera samples by using mammalian-produced Renillaluciferase-antigen fusion proteins
2005
p63 and p73: old members of a new family
2000 StandoutNobel
Increased Id-1 expression is significantly associated with poor survival of patients with prostate cancer
2007
Disruption of Paneth and goblet cell homeostasis and increased endoplasmic reticulum stress in Agr2−/− mice
2009 StandoutNobel
Malondialdehyde in benign prostate hypertrophy: a useful marker?
2003
Microwave thermotherapy for benign prostatic hyperplasia
2007
Idiopathic pulmonary fibrosis
2011 Standout
Nitinol urethral stents: long-term results in dogs
1994
Incidence of and risk factors for surgical site infection in patients with radical cystectomy with urinary diversion
2005
Lectin Domains of Polypeptide GalNAc Transferases Exhibit Glycopeptide Binding Specificity
2011 StandoutNobel
Chylothorax: Aetiology, diagnosis and therapeutic options
2009 Standout
Motor recovery after stroke: a systematic review
2009 Standout
Glycosylation in cancer: mechanisms and clinical implications
2015 Standout
Up-regulation of Akt3 in Estrogen Receptor-deficient Breast Cancers and Androgen-independent Prostate Cancer Lines
1999 Standout
Comparison of Healing after Cystotomy and Repair with Fibrin Glue and Sutured Closure in the Porcine Model
2008 StandoutNobel
NAD + /NADH and NADP + /NADPH in Cellular Functions and Cell Death: Regulation and Biological Consequences
2007 Standout
The Fibroblast Growth Factor signaling pathway
2015 Standout
Serology-Enabled Discovery of Genetically Diverse Hepaciviruses in a New Host
2012 StandoutNobel
FUNCTIONAL RESULTS OF ORTHOTOPIC ILEAL NEOBLADDER WITH SEROUS-LINED EXTRAMURAL URETERAL REIMPLANTATION: EXPERIENCE WITH 450 PATIENTS
2001
DOES THE OPTION OF THE ILEAL NEOBLADDER STIMULATE PATIENT AND PHYSICIAN DECISION TOWARD EARLIER CYSTECTOMY?
1998
Clinical practice guidelines for antimicrobial prophylaxis in surgery
2013 Standout
Role of Telomeres and Telomerase in the Pathogenesis of Human Cancer
2003
Isolation and Characterization of Tumorigenic, Stem-like Neural Precursors from Human Glioblastoma
2004 Standout
Antitumor Activity of Systemically Delivered Ribozymes Targeting Murine Telomerase RNA
2004 StandoutNobel
Natural Innate and Adaptive Immunity to Cancer
2011 Standout
A Novel Uretero-Ileal Reimplantation Technique: The Serous Lined Extramural Tunnel. A Preliminary Report
1994
Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer
2005 Standout
Genes and pathways downstream of telomerase in melanoma metastasis
2006 StandoutNobel
Bladder Cancer
2020 Standout
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
The Natural History of Renal Angiomyolipoma
1993
Increased expression of fibroblast growth factor 6 in human prostatic intraepithelial neoplasia and prostate cancer.
2000
Diagnosis, Prevention, and Treatment of Catheter-Associated Urinary Tract Infection in Adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America
2010 Standout
Relative paradigms between autoantibodies in lupus and autoantibodies in cancer
2003
The prognostic and diagnostic value of circulating tumor cells in bladder cancer and upper tract urothelial carcinoma: a meta-analysis of 30 published studies
2017
The Management of Renal Angiomyolipoma
1986
Complications of the Afferent Antireflux Valve Mechanism in the Kock Ileal Reservoir
1996
ATM Mediates Cytotoxicity of a Mutant Telomerase RNA in Human Cancer Cells
2008 StandoutNobel
Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal
2014 Standout
Canarypox Virus-Induced Maturation of Dendritic Cells Is Mediated by Apoptotic Cell Death and Tumor Necrosis Factor Alpha Secretion
2000 StandoutNobel
p53 as a target for cancer vaccines: recombinant canarypox virus vectors expressing p53 protect mice against lethal tumor cell challenge.
1996
Metallic implant biomaterials
2014 Standout
p53 Antibodies in the sera of patients with various types of cancer: a review.
2000
Microwave thermotherapy for benign prostatic hyperplasia
2012
Innate NKT lymphocytes confer superior adaptive immunity via tumor-capturing dendritic cells
2005 StandoutNobel
Cancer‐associated autoantibodies to MUC1 and MUC4—A blinded case–control study of colorectal cancer in UK collaborative trial of ovarian cancer screening
2013

Works of A. Le Duc being referenced

Endourological Treatment ofLumbar and Iliac UreteralStones
1994
Transrectal and transurethral hyperthermia versus sham treatment in benign prostatic hyperplasia: a double‐blind randomized multicentre clinical trial
1995
An in vitro comparison of urease‐induced encrustation of JJ stents in human urine
1997
The effects of transurethral resection and cystoprostatectomy on dissemination of epithelial cells in the circulation of patients with bladder cancer
1999
Telomerase activity as a potential marker in preneoplastic bladder lesions
2000
Laparoscopic Fibrin Glue Ureteral Anastomosis: Experimental Study in the Porcine Model
1996
Endoscopic Surveillance of Self-Expandable Metal Prostheses in Recurrent Urethral Strictures
1992
[Screening for cancer of the prostate using prostate-specific antigen].
1990
[Prostate-specific antigen in prostatic pathology].
1988
Immortalization of Human Adult Normal Prostatic Epithelial Cells by Liposomes Containing Large T-SV40 Gene
1991
An Original Antireflux Ureteroileal Implantation Technique: Long-Term Followup
1987
Diagnosis and Treatment of Renal Angiomyolipoma (Based on 15 Cases)
1980
Analysis of p53 antibodies in patients with various cancers define B-cell epitopes of human p53: distribution on primary structure and exposure on protein surface.
1993
Plasma Neuroendocrine Markers in Patients with Benign Prostatic Hyperplasia and Prostatic Carcinoma
1996
Rankless by CCL
2026